A review of pharmaceuticals and endocrine-disrupting compounds: Sources, effects, removal, and detections

Water, Air, and Soil Pollution

Volumn 224, Issue 11, 2013, Pages

  Tijani, Jimoh O ^a   Fatoba, Ojo O ^a   Petrik, Leslie F ^a  

^a UNIVERSITY OF THE WESTERN CAPE   (South Africa)

Author keywords

Activated carbon; Advanced oxidation process; Coagulation flocculation; Electrodialysis; Endocrine disrupting compounds; Filtration; Ozonation; Pharmaceutical and personal care products; Reverse osmosis; Sedimentation

Indexed keywords

ACTIVATED CARBON; ACTIVATED CARBON TREATMENT; BIODEGRADATION; CHEMICAL WATER TREATMENT; COAGULATION; DEVELOPING COUNTRIES; ELECTRODIALYSIS; ENDOCRINE DISRUPTERS; FILTRATION; OZONE; OZONE WATER TREATMENT; OZONIZATION; POPULATION STATISTICS; POTABLE WATER; REVERSE OSMOSIS; SEDIMENTATION; WATER SUPPLY;

ADVANCED OXIDATION PROCESSES; COAGULATION/FLOCCULATION; ENDOCRINE DISRUPTING COMPOUND; NON-GOVERNMENTAL ORGANISATIONS; PERSONAL CARE PRODUCTS; PHARMACEUTICAL AND PERSONAL CARE PRODUCTS; REGULATORY FRAMEWORKS; TERRESTRIAL ENVIRONMENTS;

WATER POLLUTION;

ACTIVATED CARBON; DRINKING WATER; DRUG; ENDOCRINE DISRUPTOR; STEROID;

ACTIVATED CARBON; COAGULATION; DRINKING WATER; DRUG; ENDOCRINE DISRUPTOR; FILTRATION; FLOCCULATION; POLLUTANT REMOVAL; POLLUTANT SOURCE; WATER POLLUTION; WATER TREATMENT;

ADVANCED OXIDATION PROCESS; ARTICLE; BIODEGRADATION; ECONOMIC DEVELOPMENT; ECOTOXICITY; ELECTRODIALYSIS; ENVIRONMENTAL EXPOSURE; ENVIRONMENTAL IMPACT ASSESSMENT; FILTRATION; FLOCCULATION; HYGIENE PRODUCT; NONHUMAN; OXIDATION; OZONATION; PERSONAL HYGIENE; PHOTOCATALYSIS; POLLUTION TRANSPORT; POPULATION DENSITY; PUBLIC HEALTH; QUANTITATIVE ANALYSIS; REVERSE OSMOSIS; SEDIMENTATION; WASTE WATER MANAGEMENT; WASTE WATER TREATMENT PLANT; WATER ANALYSIS; WATER CONTAMINATION; WATER POLLUTION CONTROL; WATER QUALITY; WATER TREATMENT;

EID: 84885766944     PISSN: 00496979     EISSN: 15732932     Source Type: Journal    
DOI: 10.1007/s11270-013-1770-3     Document Type: Article

References (231)

1. Ali Nickheslat., Mohammad Mehdi Amin, Hassan Izanloo, Ali Fatehizadeh, & Seyed Mohammad Mousavi. (2013). Phenol Photocatalytic Degradation by Advanced Oxidation Process under Ultraviolet Radiation Using Titanium Dioxide. Journal of Environmental and Public Health, Volume 2013 (2013), Article ID 815310, 9 pages
2. Al-Rifai, J. H., Khabbaz, H., & Schäfer, A. I. (2011). Removal of pharmaceuticals and endocrine disrupting compounds in a water recycling process using reverse osmosis systems. Separation and Purification Technology, 77, 60-67.
3. Andersson, A. M., Jensen, T. K., Juul, A., Petersen, J. H., Jorgensen, T., & Skakkebaek, N. E. (2007). Secular decline in male testosterone and sex hormone binding globulin serum levels in Danish population surveys. Journal of Clinical Endocrinology and Metabolism, 92, 4696-4705. (Pubitemid 350223446)
4. 2/UV system. Water Research, 37, 993-1004. (Pubitemid 36120515)
5. 2/UV treatment of clofibric acid in water: A kinetic investigation. Journal of Hazardous Materials, 103, 233-246. (Pubitemid 37324029)
6. Ankley, G. T., Brooks, B. W., Huggett, D. B., & Sumpter, J. P. (2007). Repeating history: Pharmaceuticals in the environment. Environmental Science and Technology, 41, 8211-8217. (Pubitemid 350276421)
7. Ashiya, B., & Guatam, S. K. (2011). Application of Photocatalysis for the degradation of Endocrine disrupting chemicals: Endosulphan and lindane. IJEP, 31(8), 658-665.
8. Ashton, D., Hilton, M., & Thomas, K. V. (2004). Investigating the environmental transport of human pharmaceuticals to streams in the United Kingdom. Science of the Total Environment, 333, 167-184. doi: 10.1016/j.scitotenv.2004.04.062. (Pubitemid 39208821)
9. Assmuth, T., & Louekari, K. (2001). Research for management of environmental risks from endocrine disrupters - contexts, knowledge base, methodologies and strategies. Helsinki: Finnish Environment Institute.
10. Badawy, M. I., Wahaab, R. A., & El-Kalliny, A. S. (2009). Fenton-biological treatment processes for the removal of some pharmaceuticals from industrial wastewater. Journal of Hazardous Materials, 167, 567-574.
11. Barnes, K.K., Kolpin, D.W., Meyer, M.T., Thurman, E.M., Furlong, E.T and Zaugg, S.D (2002). Water quality data for pharmaceuticals, hormones, and other organic wastewater contaminants in U.S. streams, 1999-2000. United States Geological Survey.
12. Barnhoorn, I. E. J., Bornman, M. S., Pieterssse, G. M., & Vuren, J. H. J. (2004). Histological evidence of intersex in feral sharptooth catfish (Clarias gariepinus) from an estrogen-polluted water source in Gauteng, South Africa. Environmental Toxicology, 19, 603-608. (Pubitemid 39552270)
13. Belgiorno, V., Rizzo, L., Fatta, D., Rocca, C. D., Lofrano, G., Nikolaou, A., Naddeo, V., & Meric, S. (2007). Review on endocrine disrupting-emerging compounds in urban wastewater: Occurrence and removal by photocatalysis and ultrasonic irradiation for wastewater reuse. Desalination, 215, 166-176. (Pubitemid 47278942)
14. Benotti, M. J., Trenholm, R. A., Vanderford, B. J., Standford, B. D., & Snyder, S. A. (2009). Pharmaceuticals and endocrine disrupting compounds in U.S. drinking water. Environmental Science and Technology, 43, 597-603.
15. Besse, J. P., & Garric, J. (2009). Progestagens for human use, exposure and hazard assessment for the aquatic environment. Environ Pollution, 157, 3485-3494.
16. Besse, J. P., Kausch Barreto, C., & Garric, J. (2008). Exposure assessment of pharmaceuticals and their metabolites in the aquatic environment: Application to the French situation and preliminary prioritization. J Human Ecol Ris Assess, 14(4), 665-695.
17. Besse, J. P., Latour, J. F., & Garric, J. (2012). Anticancer drugs in surface waters. What can we say about the occurrence and environmental significance of cytotoxic, cytostatic and endocrine therapy drugs? Environmental International, 39, 73-86.
18. Bisceglia, K.J. & Roberts, A.L. (2006). A usage study and preliminary environmental risk assessment for human pharmaceuticals in the United States. Environ. Sci. Technol., in preparation.
19. Blazkova, M., Mickova-Holubova, B., Rauch, P., & Fukal, L. (2009). Immunochromatographic colloidal carbon-based assay for detection of methiocarb in surface water. Biosensors and Bioelectronics, 25(4), 753-758.
20. Bolong, N., Ismail, A. F., Salim, M. R., & Matsuura, T. (2009). A review of the effects of emerging contaminants in wastewater and options for their removal. Desalination, 239, 229-246.
21. Bonefeld-Jorgensen, E. C., Long, M., Hofmeister, M. V., & Vinggaard, A. M. (2007). Endocrine-disrupting potential of bisphenol A, bisphenol A dimethacrylate, 4-n-nonylphenol, and 4-n-octylphenol in vitro: New data and a brief review. Environmental Health Perspectives, 115(Suppl. 1), 69-76.
22. Bound, J. P., & Voulvoulis, N. (2005). Household disposal of pharmaceuticals as a pathway for aquatic contamination in the United Kingdom. Environ. Health Perspectives, 113, 1705-1711. (Pubitemid 41794265)
23. Boxall, A. B. A., Fogg, L. A., Blackwell, P. A., Kay, P., Pemberton, E. J., & Croxford, A. (2004). Veterinary medicines in the environment. Reviews of Environmental Contamination and Toxicology, 180, 1-91.
24. Boyd, G. R., Reemtsma, H., Grimm, D. A., & Mitra, S. (2003). Pharmaceuticals and personal care products (PPCPs) in surface and treated waters of Louisiana, USA and Ontario, Canada. Science of the Total Environment, 311, 135-149. (Pubitemid 36773740)
25. Braga, O., Smythe, G. A., Schafer, A. I., & Feitz, A. J. (2005). Fate of steroid estrogens in Australian inland and coastal wastewater treatment plants. Environmental Science Technology 39, 3351-3358. (Pubitemid 40638279)
26. Brausch, J. M., & Rand, G. M. (2011). A review of personal care products in the aquatic environment: Environmental concentrations and toxicity. Chemosphere, 82, 1518-1532.
27. Brooks, B. W., Riley, T. M., & Taylor, R. D. (2006). Water quality of effluent-dominated stream ecosystems: Ecotoxicological, hydrological, and management considerations. Hydrobiologia, 556, 365-379. (Pubitemid 43004555)
28. Burkhardt-Holm, P., Giger, W., Güttinger, H., Ochsenbein, U., Peter, A., Scheurer, K., Suter, M. J. F., Ochsenbein, U., Segner, H., & Staub, E. (2005). Where have all the fish gone. Environmental Science and Technology, 39, 441A-447A. (Pubitemid 41572391)
29. Caliman, F. A., & Gavrilescu, M. (2009). Pharmaceuticals, personal care products and endocrine disrupting agents in the environment - a review. Clean, 37(4-5), 277-303.
30. Campbell, C. G., Borglin, S. E., Green, F. B., Grason, A., Wozei, E., & Stringfellow, W. T. (2006). Biologically directed environmental monitoring, fate, and transport of estrogenic endocrine disrupting compounds in water: A review. Chemosphere, 65, 1265-1280. (Pubitemid 44462708)
31. Carballa, M., Omil, F., Lema, J. M., Llompart, M., Garcia-Jares, C., Rodriguez, I., Gomez, M., & Ternes, T. (2004). Behavior of pharmaceuticals, cosmetics and hormones in a sewage treatment plant. Water Research, 38, 2918-2926. (Pubitemid 38829583)
32. Carballa, M., Manterola, G., Larrea, L., Ternes, T., Omil, F., & Lema, J. M. (2007). Influence of ozone pretreatment on sludge anaerobic digestion: Removal of pharmaceutical and personal care products. Chemosphere, 67, 1444-1452. (Pubitemid 46227511)
33. Chatzitakis, A., Berberidou, C., Paspaltsis, I., Kyriakou, G., Sklaviadis, T., & Poulios, I. (2008). Photocatalytic degradation and drug activity reduction of chloramphenicol. Water Research, 42, 386-394. (Pubitemid 350296247)
34. Chong, M. N., & Jin, B. (2012). Photocatalytic treatment of high concentration carbamazepine in synthetic hospital wastewater. Journal of Hazardous Materials, 199-200, 135-142.
35. Chong, M. N., Jin, B., Laera, G., & Christopher, P. S. (2011). Evaluating the photodegradation of Carbamazepine in a sequential batch photoreactor system: Impacts of effluent organic matter and inorganic ions. Chemical Engineering Journal, 174, 595-602.
36. th IWA Leading-Edge Conference on Water and Wastewater Technologies.
37. Coleman, H. M., Routledge, E. J., Sumpter, J. P., Eggins, B. R., & Byrne, J. A. (2004). Rapid loss of estrogenicity of steroid estrogens by UVA photolysis and photocatalysis over an immobilized titanium dioxide catalyst. Water Research, 38, 3233-3240. (Pubitemid 38987702)
38. Comerton, A. M., Andrews, R. C. & Bagley, D. M. (2009). Practical overview of analytical methods for endocrine disrupting compounds, pharmaceuticals and personal care products in water and wastewater. Philosophical Transactions of Royal Society A, 367(1904), 3923-3939.
39. Cortés Muñoz, J.E., Calderón Mólgora, G.C., Martín Domínguez, A., Espino de la O, E.E. Gelover Santiago, S.L., Hernández Martínez, C.L., Moeller Chávez, G.E. (2013). Endocrine disruptors in water sources: Human health risks a, INTECH Publisher (pp 1)
40. 2-assisted photocatalytic degradation of diclofenac, metoprolol, estrone and chloramphenicol as endocrine disruptors in water. Adsorption, 19, 619-630.
41. Daughton, C. G. (2002). Environmental stewardship and drugs as pollutants. Lancet, 360, 1035-1036.
42. Daughton, C. G. (2004). Non-regulated water contaminants: Emerging research. Environmental Impact Assessment Review, 24(7-8), 711-732. (Pubitemid 39239337)
43. Daughton, C. G., & Ternes, T. A. (1999). Pharmaceuticals and personal care products in the environment: Agents of subtle change? Environmental Health Perspectives, 107, 907-938. (Pubitemid 30068192)
44. Davies, L., & Welch, H. G. (2006). Increasing incidence of thyroid cancer in the United States, 1973-2002. JAMA, 295, 2164-2167.
45. Dean, C. (2007). Drugs Are in the Water. Does It Matter? http://www.nytimes.com/2007/04/03/science/earth/03water.html? -rA2&sqAcornelia%20drinking%20water&stAnyt&scpA2&pagewantedAall. Accessed 5 Nov 2009.
46. Diamanti-Kandarakis, E., Bourguignon, J. P., & Giudice, L. C. (2009). Endocrine disrupting chemicals: An Endocrine Society scientific statement. Endocrine Reviews, 30, 293-342.
47. 2 process: A kinetic study. International Journal of Chemical Engineering and Applications, 1(3), 247-250.
48. 2 materials determination of intermediates and reaction pathways. Water Research, 38, 955-964. (Pubitemid 38177462)
49. Ellis, J. B. (2006). Pharmaceutical and personal care products (PPCPs) in urban receiving waters. Environm. Poll, 144, 184-189. (Pubitemid 44316870)
50. Enewold, L., Zhu, K., & Ron, E. (2009). Rising thyroid cancer incidence in the United States by demographic and tumor characteristics, 1980-2005. Cancer Epidemiology, Biomarkers and Prevention, 18, 784-791.
51. Esmaeli, R., Hassani, A. H., Eslami, A., Ahmadi Moghadam, M., & Safari, A. A. (2011). Di-(2-ethylhexyl) phthalate oxidative degradation by Fenton process in synthetic and real petrochemical wastewater. Iran. J. Environ. Health. Sci. Eng., 8(3), 201-206.
52. Esplugas, S., Bila, D. M., Krause, L. G. T., & Dezotti, M. (2007). Ozonation and advanced oxidation technologies to remove endocrine disrupting chemicals (EDCs) and pharmaceuticals and personal care products (PPCPs) in water effluents. Journal of Hazardous Materials, 149(3), 631-642. (Pubitemid 350018965)
53. 2 photocatalytic treatment of naproxen: Degradation, mineralization, intermediates and toxicity. J. Adv. Oxid. Technol, 11(3), 436-445.
54. Falconer, I. R., Chapman, H. F., Moore, M. R., & Ranmuthugala, G. (2006). Endocrine-disrupting compounds: A review of their challenge to sustainable and safe water supply and water reuse. Environmental Toxicology, 21, 181-191.
55. Farré, M., Kantiani, L., Perez, S., & Barcelo, D. (2009). Sensors and biosensors in support of EU Directives. Trends in Analytical Chemistry, 28(2), 170-185.
56. Fatoki, O. S., & Opeolu, B. O. (2009). Studies on the occurrence and quantification of phenolic endocrine disruptors in water. Scientific Research and Essay, 4(12), 1415-1422.
57. Fawell, J., & Ong, C. N. (2012). Emerging contaminants and the implications for drinking water. International Journal of Water Resources Development, 28(2), 247-263.
58. Fent, K., Weston, A. A., & Caminada, D. (2006). Ecotoxicology of human pharmaceuticals. Aquatic Toxicology, 76, 122-159. (Pubitemid 43087657)
59. Ferraz, N., Carnevi Nande, G., Rossotti, M., Miguez, M. N., Last, J. A., & Gonzalez-Sapienza, G. (2007). Specific immunoassays for endocrine disruptomonitoring using recombinant antigens cloned by degenerated primePCR. Analytical and Bioanalytical Chemistry, 389, 2195-2202. (Pubitemid 350198036)
60. Fick, J., Soderstrom, H., Lindberg, R. H., Phan, C., Tysklind, M., & Larsson, D. G. J. (2009). Contamination of surface, ground, and drinking water from pharmaceutical production. Environmental Toxicology and Chemistry, 28, 2522-2527.
61. Flint, S., Markle, T., Thompson, S., & Wallace, E. (2012). Bisphenol A exposure, effects, and policy: A wildlife perspective. Journal of Environmental Management, 104, 19-34.
62. Focazio, M. J., Kolpin, D. W., Barnes, K. K., Furlong, E. T., Meyer, M. T., Zaugg, S. D., Barber, L. B., & Thurman, M. E. (2008). A national reconnaissance for pharmaceuticals and other organic wastewater contaminants in the United States - II) Untreated drinking water sources. Science of the Total Environment, 402, 201-216.
63. Friedmann, D., Mendive, C., & Bahnemann, D. (2010). TiO2 for water treatment: parameters affecting the kinetics and mechanisms, of photocatalysis. Applied Catalysis B, 99, 398-406.
64. Frontistis, Z., Daskalaki, V. M., Hapeshi, E., Drosou, C., Fatta-Kassinos, D., Xekoukoulotakis, N. P., & Mantzavinos, D. (2012). Photocatalytic (UV-A/TiO2) degradation of 17α-ethynylestradiol in environmental matrices: Experimental studies and artificial neural network modelling. Journal of Photochemistry and Photobiology A: Chemistry, 240, 33-41.
65. Game, C., Gagnon, M. M., Webb, D., & Lim, R. (2006). Endocrine disruption in male mosquitofish (Gambusia holbrooki) inhabiting wetlands in Western Australian. Ecotoxicol., 15, 665-672. (Pubitemid 44764297)
66. Garric, J., & Ferrari, B. (2005). Pharmaceuticals in aquatic ecosystems. Levels of exposure and biological effects: A review. Revue des sciences de l'eau, 18, 307-330. (Pubitemid 43109501)
67. Gatidou, G., Thomaidis, N., Stasinakis, A., & Lekkas, T. (2007). Simultaneous determination of the endocrine disrupting compounds nonylphenol, nonylphenol ethoxylates, triclosan and bisphenol A in wastewater and sewage sludge by gas chromatography-mass spectrometry. Journal of Chromatography A, 1138(1-2), 32-41. (Pubitemid 44908343)
68. Giri, R. R., Ozaki, H., Ota, S., Takanami, R., & Taniguchi, S. (2010). Degradation of common pharmaceuticals and personal care products in mixed solutions by advanced oxidation techniques. Int. J. Environ. Sci. Tech., 7(2), 251-260.
69. Glassmeyer, S. T., Furlorg, E. T., Kolpin, D. W., Cahill, J. D., Zuagg, S. D., Werner, S. L., Meyer, M. T., & Kryak, D. D. (2005). Transports of chemicals and microbial compounds from known wastewater discharges: Potential for use as indicators of human fecal contamination. Environmental Science and Technology, 39, 5157-5169.
70. Gogate, P. R., & Pandit, A. B. (2004). A review of imperative technologies for wastewater. Chemosphere, 73, 848-853.
71. Gulkowska, A., Leung, H. W., So, M. K., Taniyasu, S., Yamashita, N., Yeung, L. W. Y., Richardson, B. J., Lei, A. P., Giesy, J. P., & Lam, P. K. S. (2008). Removal of antibiotics from wastewater by sewage treatment facilities in Hongkong and Shenzhen, China. Water Research, 42(1-2), 395-403. (Pubitemid 350296248)
72. Gunnarsson, L., Adolfsson-Erici, M., Björlenius, B., Rutgersson, C., Förlin, L., & Larsson, D. G. J. (2009). Comparison of six different sewage treatment processes - reduction of estrogenicsubstances and effects on gene expression in exposed male fish. Science of the Total Environment, 407, 5235-5242.
73. Ha, M. H., Lee, D. H., & Jacobs, D. R. (2007). Association between serum concentrations of persistent organic pollutants and self-reported cardiovascular disease prevalence: Results from the National Health and Nutrition Examination Survey, 1999-2002. Environmental Health Perspectives, 115, 1204-1209.
74. Halling-Sørensen, B., Nors Nielsen, S., Lanzky, P. F., Ingerslev, F., Holten Lützhøft, H. C., & Jørgensen, S. E. (1998). Occurrence, fate and effects of pharmaceutical substances in the environment-a review. Chemosphere, 36(2), 357-393. (Pubitemid 27514266)
75. Harrison, P. T. C. (2001). Endocrine disrupters and human health. Brit. Med. J., 323, 1317-1318.
76. Harrison, E. Z., Oakes, S. R., Hysell, M., & Hay, A. (2006). Organic chemicals in sewage sludges. Science of the Total Environment, 367, 481-497. (Pubitemid 44093710)
77. Hartmann, J., Bartels, P., Mau, U., Witter, M., Tumpling, W. V., & Hofmann, J. (2008). Degradation of the drug diclofenac in water by sonolysis in presence of catalyst. Chemosphere, 70, 453-461. (Pubitemid 350101715)
78. Heberer, T. (2002). Occurrence, fate, and removal of pharmaceutical residues in the aquatic environment: A review of recent research data. Toxicology Letters, 131, 5-17. (Pubitemid 34461906)
79. Heberer, T., & Feldman, D. (2005). Contribution of effluents from hospitals and private households to the total loads of diclofenac and carbamazepine in municipal sewage effluent modelling versus measurement. J.Hazardous Materials, 122, 211-218. (Pubitemid 40828487)
80. Hecker, M., & Giesy, J. P. (2008). Novel trends in endocrine disrupting testing: The H295R steroidogenesis assay for identification of inducers and inhibitors of hormone production. Analytical and Bioanalytical Chemistry, 390, 287-291.
81. Hileman, B. (2005). Antiseptic soaps under scrutiny: FDA to assess whether household use leads to bacterial resistance. Chemical and Engineering News, 83, 14.
82. Hill, S. S., Shawa, B. R., & Wuc, A. H. B. (2001). The clinical effects of plasticizers, antioxidants, and other contaminants in medicapolyvinylchloride tubing during respiratory and non-respiratoexposure. Review. Clin. Chim. Acta, 304, 1-8. (Pubitemid 32124733)
83. Houeto, P., Carton, A., Guerbet, M., Mauclaire, A. C., Gatignol, C., & Lechat, P. (2012). Assessment of the health risks related to the presence of drug residues in water for human consumption: Application to carbamazepine. Regul Toxicol Pharm, 62(1), 41-48.
84. Houtman, C. J. (2010). Emerging contaminants in surface water and their relevance for the production of drinking water in Europe. Journal of Integrative Environmental Sciences, 7(4), 271-295.
85. 2 Nanowires During Water Treatment. Waste Biomass Valor.
86. Huang, P. C., Tien, C. J., Sun, Y. M., Hsieh, C. Y., & Lee, C. C. (2008). Occurrence of Phthalates in sediment and biota: Relationship to aquatic factors and the biota-sediment accumulation factor. Chemosphere, 73, 539-544.
87. Huertas-Perez, J. F., & Garcia-Campana, A. M. (2008). Determination of N-methylcarbamate pesticides in water and vegetable samples by HPLC with postcolumn chemiluminescence detection using the luminol reaction. Analytica Chimica Acta, 630(2), 194-204.
88. Huyghe, E., Matsuda, T., & Thonneau, P. (2003). Increasing incidence of testicular cancer worldwide: A review. Journal of Urology, 170, 5-11. (Pubitemid 36734401)
89. Iwuoha, E. I. (2012). Smart nano-dimensional dendritic aptasensor for real-time determination of estrogenic 17β-estradiol. International conference and exhibition on biosensors and bioelectronics. May 14-16, 2012 Embassy Suites Las Vegas, USA.
90. Jackson, J., & Sutton, R. (2008). Sources of endocrine-disrupting chemicals in urban wastewater, Oakland, CA. Science of the Total Environment, 405, 153-160.
91. Janex-Habibi, M. L., Bruchet, A., & Ternes, T. A. (2004). Effect of drinking water treatment and waste water treatment on drug residues. Results of the Poseidon Project. Techniques, Sciences, Methods, 11, 59-67. (Pubitemid 40099081)
92. Jiao, B., & Cheng, C. H. K. (2008). Disruption actions of bisphenol A and malachite green on growth hormone receptor gene expression and signal transduction in seabream. Fish Physiology and Biochemistry, 36(2), 251-261.
93. Jin, X. L., Jiang, G. B., Huang, G. L., Liu, J. F., & Zhou, Q. F. (2004). Determination of 4-tert-octylphenol, 4-nonylphenol and bisphenol A in surface waters from the Haihe River in Tianjin by gas chromatography-mass spectrometry with selected ion monitoring. Chemosphere, 56(11), 1113-1119.
94. Johnson, D. M., Hokanson, D. R., Zhang, Q., Czupinski, K. D., & Tang, J. (2008). Feasibility of water purification technology in rural areas of developing countries. Journal of Environmental Management, 88, 416-427. (Pubitemid 351696567)
95. Jones-Lepp, T. L., & Stevens, R. (2007). Pharmecuticals and personal care products in biosolids/sewage sludge: The interface between analytical chemistry and regulation. Analytical and Bioanalytical Chemistry, 387, 1173.
96. José, H. J., Gebhardt, W., Moreira, R. F. P. M., Pinnekamp, J., & Schröder, H. F. (2010). Advanced oxidation processes for the elimination of drugs resisting biological membrane treatment. Ozone: Science & Engineering, 32, 305-312.
97. Joseph, L., Heo, J., Park, Y.-G., Flora, J. R. V., & Yoon, Y. (2011). Adsorption of bisphenol A and 17α-ethinyl estradiol on single walled carbon nanotubes from seawater and brackish water. Deslination, 281, 68-74.
98. Kasprzyk-Hordern, B., Dinsdale, R. M., & Guwy, A. J. (2009). The removal of pharmaceuticals, personal care products, endocrine disruptors and illicit drugs during wastewater treatment and its impact on the quality of receiving waters. Water Research, 43(2), 363-380.
99. Kidd, K. A., Blanchfield, P. J., Mills, K. H., Palace, V. P., Evans, R. E., Lazorchak, J. M., & Flick, R. W. (2007). Collapse of a fish population after exposure to a synthetic estrogen. Proceeding of the National Academy of Sciences, 104, 8897-8901. (Pubitemid 47175408)
100. Kim, S. D., Cho, J., Kim, I. S., Vanderford, B. J., & Snyder, S. A. (2007). Occurrence and removal of pharmaceuticals and endocrine disruptors in South Korean surface, drinking and waste waters. Water Research, 41, 1013-1021. (Pubitemid 46215707)
101. 2 treatments. Chemosphere, 77, 518-525.
102. Kinney, C. A., Furlong, E. T., Kolpin, D. W., Burkhardt, M. R., Zaugg, S. D., Werner, S. L., Bossio, J. P., & Benotti, M. J. (2008). Bioaccumulation of pharmaceuticals and other anthropogenic waste indicators in earthworms from agricultural soil amended with biosolid or swine manure. Environmental Science & Technology, 42, 1863-1870. (Pubitemid 351497672)
103. Klavarioti, M., Mantzavinos, D., & Kassinos, D. (2009). Removal of residual pharmaceuticals from aqueous systems by advanced oxidation processes. Environment International, 35, 402-417.
104. Klecka, G.M., Staples, C.A., Clark, K.E., Van der Hoeven, N., Thomas, D.E., & Hentges, S.G., (2009). Exposure analysis of bisphenol-A in surface water Systems North America and Europe. Environmental Science and Technology, 6145-6150.
105. Kolpin, D. W., Furlong, E. T., Meyer, M. T., Thurman, E. M., Zaugg, S. D., Barber, L. B., & Buxton, H. T. (2002). Pharmaceuticals, hormones and other organic wastewater contaminants in U.S. streams, 1999-2000: A national reconnaissance. Environmental Science and Technology, 36, 1202-1211. (Pubitemid 34228893)
106. Kümmerer, K., & Al-Ahmad, A. (2010). Estimation of the cancer risk to humans resulting from the presence of cyclophosphamide and ifosfamide in surface water. Environmental Science and Pollution Research, 17, 486-496.
107. Lafi, W.K., & Al-Qodah, Z. (2006). Combined advanced oxidation and biological treatment processes for the removal of pesticides from aqueous solutions. Journal of Hazardous Materials, B137: 489:49.
108. Larsen, T. A., Lienert, J., Joss, A., & Siegrist, H. (2004). How to avoid pharmaceuticals in the aquatic environment. Journal of Biotechnology, 113, 295-304. (Pubitemid 39237085)
109. Larsson, D. G. J., de Pedro, C., & Paxeus, N. (2007). Effluent from drug manufactures contains extremely high levels of pharmaceuticals. J. Hazardous Materials, 148, 751-755. (Pubitemid 47334856)
110. Le Blanc, F. A., Albrecht, C., Bonn, T., Fechner, P., Proll, G., Pro, F., II, Carlquist, M., & Gauglitz, G. (2009). A novel analytical tool for quantification of estrogenicity in river water based on fluorescence labelled estrogen receptor a. Analytical and Bioanalytical Chemistry, 395(6), 1769-1776.
111. Lear, J. C., Maillard, J. Y., Dettmar, P. W., Goddard, P. A., & Russell, A. D. (2002). Chloroxylenol- and triclosan-tolerant bacteria from industrial sources. Journal of Industrial Microbiology and Biotechnology, 29, 238-242. (Pubitemid 35379593)
112. Lee, L. S., Strock, T. J., Sarmah, A. K., & Rao, P. S. C. (2003). Sorption and dissipation of testosterone, estrogens, and their primary transformation products in soils and sediment. Environmental Science and Technology, 37, 4098-4105. (Pubitemid 37108294)
113. Li, Y., Niu, J., Yin, L., Wang, W., Bao, Y., Chen, J., & Duan, Y. (2011). Photocatalytic degradation kinetics and mechanism of pentachlorophenol based on superoxide radicals. Journal of Environmental Sciences, 23(11), 1911-1918.
114. Lin, A. Y. C., Yu, T. H., & Lin, C. F. (2008). Pharmaceutical contamination in residential, industrial and agricultural waste streams: Risk to aqueous environments in Taiwan. Chemosphere, 74, 131.
115. 2 catalyst. Journal of Nanjing Forestry University, 37(4), 90-94.
116. 2 degradation of endocrine-disrupting chemicals in water evaluated via toxicity assays. Water Science and Technology, 55, 313-319. (Pubitemid 47214909)
117. Lindqvist, N., Tuhkanen, T., & Kronberg, L. (2005). Occurrence of acidic pharmaceuticals in raw and treated sewages and in receiving waters. Water Research, 39(11), 2219-2228. (Pubitemid 40840674)
118. Lishman, L., Smyth, S. A., Sarafin, K., Kleywegt, S., Toito, J., Peart, T., Lee, B., Servos, M., Beland, M., & Seto, P. (2006). Occurrence and reduction of pharmaceuticals and personal care products and estrogens by municipal wastewater treatment plants in Ontario. Canada. Sci. Total Environ., 367, 544-558. (Pubitemid 44109889)
119. Liu, Z.-h., Kanjo, Y., & Mizutani, S. (2009). Removal mechanisms for endocrine disrupting compounds (EDCs) in wastewater treatment - physical means, biodegradation, and chemical advanced oxidation: A review. Science of the Total Environment, 407, 731-748.
120. Liu, Y., Guan, Y. T., Tam, N. F. Y., Mizuno, T., Tsuno, H., & Zhu, W. P. (2010). Influence of rainfall and basic water quality parameters on the distribution of endocrine-disrupting chemicals in coastal area. Water, Air, and Soil Pollution, 209, 333-343.
121. 2 degradations of pharmaceutical intermediates in aqueous solution. J. Photochem. Photobiol., 156, 121-126. (Pubitemid 36285505)
122. Lyons, M. (2008). Is there something. In: The water? http://chicagoist. com/2008/04/17/is-there-someth.php. Accessed 5 Nov 2009).
123. Machulek, Jr. A., Silvio C. Oliveira, Marly E. Osugi, Valdir S. Ferreira, Frank H. Quina, Renato F. Dantas, Samuel L. Oliveira, Gleison A. Casagrande, Fauze J. Anaissi, Volnir O. Silva, Rodrigo P. Cavalcante, Fabio Gozzi, Dayana D. Ramos, Ana P.P. da Rosa, Ana P.F. Santos, Douclasse C. de Castro, & Jéssica A. Nogueira. (2013). Application of Different Advanced Oxidation Processes for the Degradation of Organic Pollutants. Chapter 6, INTECH publisher Organic Pollutants - Monitoring, Risk and Treatment. Pp 142.
124. Mackenzie, C. A., Lockridge, A., & Keith, M. (2005). Declining sex ratio in a first nation community. Environmental Health Perspectives, 113(10), 1295-1298. (Pubitemid 41511982)
125. Madhavan, J., Grieser, F., & Ashokkumar, M. (2010). Combined advanced oxidation processes for the synergistic degradation of ibuprofen in aqueous environments. Journal of Hazardous Materials, 178(1), 202-208.
126. Maletz, S., Floehr, T., Beier, S., Klümper, C., Brouwer, A., Behnisch, P., Higley, E., Giesy, J. P., Heckerd, M., Gebhardt, W., Linnemann, V., Pinnekamp, J., & Hollert, H. (2013). In vitro characterization of the effectiveness of enhanced sewage treatment processes to eliminate endocrine activity of hospital effluents. Water Research, 47(4), 1545-1557.
127. Mara, D. D. (2003). Water, sanitation and hygiene for the health of developing nations. Public Health, 452-456. (Pubitemid 37321775)
128. Marchesini, G. R., Koopal, K., Meulenberg, E., Haasnoot, W., & Irth, H. (2007). Spreetabased biosensor assays for endocrine disruptors, Biosen. Bioelectron., 22(9-10), 1908-1915. (Pubitemid 46349623)
129. Mastin, J. P. (2005). Environmental cardiovascular disease. Cardiovascular Toxicology, 5, 91-94. (Pubitemid 41058624)
130. Matos T.A.F., Dias A.L.N., Reis A.D.P., Apolinário da Silva M.R., & Kondo M.M. (2012). Degradation of Abamectin Using the Photo-Fenton Process. International Journal of Chemical Engineering, Article ID 915724, 7 pages.
131. Mauricio, R., Diniz, M., Petrovic, M., Amaral, L., Peres, I., Barcel, O.
132. McClellan, K., & Halden, R. U. (2010). Pharmaceuticals and personal care products in archived U.S. biosolids from the 2001 EPA national sewage sludge survey. Water Research, 44, 658-668.
133. 2 and simulated solar irradiation. Water Research, 42, 585-594. (Pubitemid 351625252)
134. Michael, J. (2001). Are problems with male reproductive health caused by endocrine disruption? Occup Med Educ, 58, 281-288
135. Moder, M., Braun, P., Lange, F., Schrader, S., & Lorenz, W. (2007). Determination of endocrine disrupting compounds and acidic drugs in water by coupling of derivatization, gas chromatograph and negative chemical ionization mass spectrometry. Clean Air Soil Water, 35(5), 444-451. (Pubitemid 350162288)
136. Moldovan, Z. (2006). Occurrences of pharmaceutical and personal care products as micropollutants in rivers from Romania. Chemosphere, 64, 1808-1817. (Pubitemid 44092955)
137. Montgomery, M. A., & Elimelech, M. (2007). Water and sanitation in developing countries: Including health in the equation. Environmental Science and Technology, 41, 17-24.
138. Moore, M., Gould, P., & Keary, B. S. (2003). Global urbanization and impact on health. International Journal of Hygiene and Environmental Health, 206, 269-278. (Pubitemid 37039996)
139. Mottaleb, M. A., Usenko, S., O'Donnell, J. G., Ramirez, A. J., Brooks, B. W., & Chambliss, C. K. (2009). Gas chromatography-mass spectrometry screening methods for select UV filters, synthetic musks, alkylphenols, an antimicrobial agent, and an insect repellent in fish. Journal of Chromatography A, 1216(5), 815-823.
140. Murray, T. J., Lea, R. G., Abramovich, D. R., Haites, N. E., & Fowler, P. A. (2001). Early Pregnancy. Biologie et Médecine, 5, 80-112.
141. Naa, S., Ahnb, Y.-G., Cui, M., & Khim, J. (2012). Significant diethyl phthalate (DEP) degradation by combined advanced oxidation process in aqueous solution. Journal of Environmental Management, 101, 104-110.
142. Nakada, N., Tanishima, T., Shinohara, H., Kiri, K., & Takada, H. (2006). Pharmaceutical chemicals and endocrine disrupters in municipal wastewater in Tokyo and their removal during activated sludge treatment. Water Research, 40(17), 3297-3303. (Pubitemid 44332504)
143. Nakada, N., Shinohara, H., Murata, A., Kiri, K., Managaki, S., Sato, N., & Takada, H. (2007). Removal of selected pharmaceuticals and personal care products (PPCPs) and endocrine-disrupting chemicals (EDCs) during sand filtration and ozonation at a municipal sewage treatment plant. Water Research, 41(19), 4373-4382. (Pubitemid 47603193)
144. 2-modified polytetrafluoroethylene mesh sheets. Journal of Photochemistry and Photobiology, A: Chemistry, 160, 115-120.
145. Nakonechnya, M., Ikehataa, K., & El-Dina, M. G. (2008). Kinetics of Estrone Ozone/Hydrogen Peroxide Advanced Oxidation Treatment. Ozone Science and Engineering, 30, 249-255.
146. Naz, R. K. (2005). Endocrine disruptors: Effects on male and female reproductive systems Boca Raton. FL: CRC Press.
147. Ning, B., Graham, N., Zhang, Y., Nakonechny, M., & El-Din, M. G. (2007). Degradation of Endocrine Disrupting Chemicals by Ozone/AOPs. Ozone Science and Engineering, 29, 153-176. (Pubitemid 46908494)
148. Nowotny, N., Epp, B., vonSonntag, C., & Fahlenkamp, H. (2007). Quantification and modeling of the elimination behavior of ecologically problematic wastewater micropollutants by adsorption on powdered and granulated activated carbon. Environmental Science and Technology, 41(6), 2050-2055. (Pubitemid 46449241)
149. Oller, I., Malato, S., Sánchez-Pérez, J. A., Gernjak, W., Maldonado, M. I., & Pérez-Estrada, L. A. (2007). A combined solar photocatalytic-biological field system for the mineralization of an industrial pollutant at pilot scale. Catalysis Today, 122, 150-159. (Pubitemid 46546619)
150. Oller, I., Malato, S., & Sánchez-Pérez, J. A. (2011). Combination of advanced oxidation processes and biological treatments for wastewater decontamination - A review. Science of the Total Environment, 409, 4141-4166.
151. Olujimi, O. O., Fatoki, O. S., Odendaal, J. P., & Okonkwo, J. O. (2010). Endocrine disrupting chemicals (phenol and phthalates) in the South African environment: A need for more monitoring. Review. Water SA, 36(5), 671-682.
152. Ortiz de García, S., PintoPinto, G., García Encina, P., & Mata, R. I. (2013). Consumption and occurrence of pharmaceutical and personal care products in the aquatic environment in Spain. Science of the Total Environment, 444, 451-465.
153. Palace, V. P., Evans, R. E., Wautier, K. G., Mills, K. H., Blanchfield, P. J., & Park, B. J. (2009). Interspecies differences in biochemical, histopathological, and population responses in four wild fish species exposed to ethynylestradiol added to a whole lake. Canada J. Fish Aquat Sci, 66, 1920-1935.
154. Peng, X., Yiyi, Y., Tang, C., Tan, J., Huang, Q., & Wang, Z. (2008). Occurrence of steroid estrogens, endocrine-disrupting phenols, and acid pharmaceutical residues in urban riverine water of the Pearl River Delta, South China. Science of the Total Environment, 397, 158-166.
155. Pereira, V. J., Linden, K. G., & Weinberg, H. S. (2007). Evaluation of UV irradiation for photolytic and oxidative degradation of pharmaceutical compounds in water. Water Research, 41, 4413-4423. (Pubitemid 47599577)
156. Perez-Estrada, L. A., Malato, S., Gernjak, W., Aguera, A., Thurman, E. M., & Ferrer, I. (2005). Photo- Fenton degradation of diclofenac: Identification of main intermediates and degradation pathway. Environmental Science and Technology, 39, 8300-8306. (Pubitemid 41572416)
157. Petrovic, M., Eljarrat, E., Lopez de Alda, M. J., & Barcelo, D. (2004). Endocrine disrupting compounds and other emerging contaminants in the environment: A survey on new monitoring strategies and occurrence data. Analytical and Bioanalytical Chemistry, 378, 549.
158. Petrovic, M., Gonalez, S., & Barcelo, D. (2003). Analysis and removal of emerging contaminants in wastewater and drinking water. Trends in Analytical Chemistry, 22(10),685-696. (Pubitemid 37509935)
159. Pryor, S. W., Hay, A. G., & Walker, L. P. (2002). Nonylphenol in anaerobically digested sewage sludge from New York State. Environmental Science and Technology, 36, 3678-3682. (Pubitemid 35006318)
160. Qin, M., Yang, H., Chen, S., Xie, H., & Guan, J. (2012). Photochemical characteristics of diclofenac and its photooxidation of inclusion complexes with β-cyclodextrins. Quimica Nova, 35, 559-562.
161. Rahman, M. F., Yanful, E. K., & Jasim, S. Y. (2009a). Occurrences of endocrine disrupting compounds and pharmaceuticals in the aquatic environment and their removal from drinking water: Challenges in the context of the developing world. Desalination, 248, 578-585.
162. Rahman, M. F., Yanful, E. K., & Jasim, S. Y. (2009b). Endocrine disrupting compounds (EDCs) and pharmaceuticals and personal care products (PPCPs) in the aquatic environment: Implications for the drinking water industry and global environmental health. Journal of Water and Health, 7(2), 224-243.
163. Rajeswari, R., & Kanmani, S. (2009). TiO2-based heterogeneous photocatalytic treatment combined with ozonation for carbendazim degradation. Iran. J. Environ. Health. Sci. Eng., 6(2), 61-66.
164. 2 catalysts. (In press).
165. Richardson, S. D., & Ternes, T. A. (2005). Water analysis: Emerging contaminants and current issues. Analytical Chemistry, 77, 3807-3838.
166. Roberts, P. H., & Thomas, K. V. (2006). The occurrence of selected pharmaceuticals in wastewater effluent and surface waters of the lower Tyne catchment. Science of the Total Environment, 356, 143-153. (Pubitemid 43246938)
167. Rodriguez-Mozaz, S., Lopeéz de Alda, M. J., & Barcelo, D. (2006). Biosensors as useful tools for environmental analysis and monitoring. Analytical and Bioanalytical Chemistry, 386(4), 1025-1041.
168. Rogers, J. A., Metz, L., & Wee Yong, V. (2013). Review: Endocrine disrupting chemicals and immune responses: A focus on bisphenol-A and its potential mechanisms. Molecular immunology, 53, 421-430.
169. Rosal, R., Rodríguez, A., Perdigón-Meló, J. A., Petre, A., Roefer, P., Synder, S., Zegers, R. E., Rexing, D. J., & Fronk, J. L. (2010). Endocrine disrupting chemicals in a source water. J. Am.WaterWorks Assoc, 92, 52-58. 92.
170. Rossnera, A., Snyder, S. A., & Knappe, D. R. U. (2009). Removal of emerging contaminants of concern by alternative adsorbents. Water Research, 43, 3787-3796.
171. Safe, S. H. (2000). Endocrine disruption and human health-is there a problem? An update. Environmental Health Perspectives, 108(6), 487-493. (Pubitemid 30453768)
172. 2 process: Optimization, kinetics and toxicity studies. Journal of Hazardous Materials, 157, 269-276.
173. 2 process and employing a new method in kinetic study. Journal of Hazardous Materials, 144, 506-512. (Pubitemid 46719645)
174. Saien, J., Ojaghloo, Z., Soleymani, A. R., & Rasoulifard, M. H. (2011). Homogeneous and heterogeneous AOPs for rapid degradation of Triton X-100 in aqueous media via UV light, nano titania hydrogen peroxide and potassium persulfate. Chemical Engineering Journal, 167, 172-182.
175. Samir, K. K., Xie, B., Thompson, M. L., Sung, S. W., Ong, S. K., & Leeuvent, J. V. (2006). Fate, transport, and biodegradation of natural estrogens in the environment and engineered systems. Environmental Science and Technology, 40, 6537-6546. (Pubitemid 44721889)
176. Schug, T. T., Janesick, A., Blumberg, B., & Heindel, J. J. (2011). Endocrine disrupting chemicals and disease susceptibility. The Journal of Steroid Biochemistry and Molecular Biology, 127, 204-215.
177. Segner, H. (2005). Developmental, reproductive, and demographic alterations in aquatic wildlife: Establishing causality between exposure to endocrine-active compounds (EACs) and effects. Acta Hydrochem. Hydrobiol., 33(1), 17-26. (Pubitemid 40829888)
178. Sellin, M. K., Snow, D. D., Schwarz, M., Carter, B. J., & Kolok, A. S. (2009). Agrichemicals in Nebraska, USA, watersheds: Occurrence and endocrine effects. Environmental Toxicology and Chemistry/SETAC, 28, 2443-2448.
179. Shannon, M. A., Bohn, P. W., Elimelech, M., Georgiadis, J. G., Mariňas, B. J., & Mayes, A. M. (2008). Science and techonology for water purification in the coming decades. Nature, 452(20), 301-310. (Pubitemid 351430783)
180. Sharpe, R. M., & Irvine, D. S. (2004). How strong is the evidence of a link between environmental chemicals and adverse effects on human health? Brit. Med. J., 328, 447-451. (Pubitemid 38250604)
181. Shemer, H., Kunukcu, Y. K., & Linden, K. G. (2006). Degradation of the pharmaceutical metronidazole via UV, Fenton and photo-Fenton processes. Chemosphere, 63, 269-276.
182. Shin, J., Moon, H. J., Kang, H., Kim, T. S., Lee, S. J., Alin, J. Y., Bae, H., Jeung, E. B., & Han, S. Y. (2007). OECD validation of the rodent Hershberger assay using three reference chemicals 17 α-methyltestorone, procymidore and PP-DDE. Archives of Toxicology, 81, 309-318. (Pubitemid 46701596)
183. 2 photocatalysis: A review. International Journal of Photoenergy, 185159, 1-23.
184. Snyder, S. A., Adham, S., Redding, A. M., Cannon, F. S., Decarolis, J., Oppenheimer, J., Wert, E. C., & Yoon, Y. (2006). Role of membranes and activated carbon removal of endocrine disruptors and pharmaceuticals. Desalination, 202, 156-181.
185. Snyder, S. A., Adham, S., Redding, A. M., Cannon, F. S., DeCarolis, J., Oppenheimer, J., Wert, E. C., & Yoon, Y. (2007). Role of membranes and activated carbon in the removal of endocrine disruptors and pharmaceuticals. Desalination, 202(1-3), 156-181. (Pubitemid 44829082)
186. Stasinakis, A. S. (2008) Use of selected advanced oxidation processes (AOPs) for wastewater treatment - a mini review. Water and Air Quality Laboratory, Department of Environment University of the Aegean, University Hill, Mytilene 81100, Greece.
187. Strauch, K. A. (2011). The impact of pharmaceuticals in the water supply. AAOHN Journal, 59(12), 525-532.
188. Suarez, S., Carballa, M., Omil, F., & Lema, J. M. (2008). How are Pharmaceutical and Personal Care Compounds Removed from Urban Wastewaters. Reviews in Environmental Science and Biotechnology, 7, 125.
189. Sui, Q., Huang, J., Deng, S., Gang, Y., & Fan, Q. (2010). Occurrence and removal of pharmaceuticals, caffeine and DEET in wastewater treatment plants of Beijing, China. Water Research, 44, 417-426.
190. Sumpter, J. P. (2005). Endocrine disruptor in the aquatic environment: A review. Acta Hydrochem. Hydrobiol., 33(1), 9-16. (Pubitemid 40829887)
191. Swaminathan, M., Muruganandham M., & Sillanpaa, M. (2013). advanced oxidation processes for wastewater treatment. International Journal of Photoenergy, Article ID 683682, 3 pages.
192. Swan, S. H., Elkin, E. P., & Fenster, L. (2000). The question of declining sperm density revisited: An analysis of 101 studies published 1934-1996. Environmental Health Perspectives, 108, 961-966.
193. Swati, M., Rema, T., & Joseph, K. (2008). Hazardous organic compounds in urban municipal solid waste from a developing country. Journal of Hazardous Materials, 160, 213.
194. Tamtam, F., Mercier, F., Le Bot, B., Eurin, J., Dinh, Q. T., Clement, M., & Chevreuil, M. (2008). Occurrence and fate of antibiotics in the Seine river in various hydrological conditions. Science of the Total Environment, 393, 84-95.
195. Ternes, T. A., & Joss, A. (2006). Human pharmaceuticals, hormones and fragrances. New York: IWA Publishing.
196. Ternes, T. A., Meisenheimer, M. M., Dowell, D., Sacher, F., Brauchg, H., Haist-Gulde, B., Preuss, G., Wilme, U., & Zulei-Seibert, N. (2002). Removal of pharmaceuticals during drinking water treatment. Environmental Science and Technology, 36, 3855-3863. (Pubitemid 35006342)
197. Ternes, T. A., Joss, A., & Siegrist, H. (2004). Scrutinizing pharmaceuticals and personal care products in wastewater treatment. Environmental Science and Technology, 38, 392A.
198. Thorpe, K. L., Cummings, R. I., Hutchinson, T. H., Scholze, M., Brighty, G., Sumpter, J. P., & Tyler, C. R. (2003). Relative Potencies and combination effects of steroidal estrogens in fish. Environmental Science and Technology, 37, 1142-1149. (Pubitemid 36504981)
199. Tixier, C., Singer, H. P., Oellers, S., & Muller, S. R. (2003). Occurrence and fate of carbamazepine, clofibric acid, diclofenac, ibuprofen, ketoprofen, and naproxen in surface waters. Environmental Science and Technology, 37, 1061-1068. (Pubitemid 36504969)
200. Topp, E., Monteiro, S. C., Beck, A., Coelho, B. B., Boxall, A. B. A., Duenk, P. W., Kleywegt, S., Lapen, D. R., Payne, M., Sabourin, L., Li, H. X., & Metcalfe, C. D. (2008). Runoff of pharmaceuticals and personal care products following application of biosolids to an agricultural field. Science of the Total Environment, 396, 52.
201. Travison, T. G., Araujo, A. B., O'Donnell, A. B., Kupelian, V., & McKinlay, J. B. (2007). A population level decline in serum testosterone levels in American men. Journal of Clinical Endocrinology and Metabolism, 92, 196-202. (Pubitemid 46075010)
202. Trenholm, R. A., Vanderford, B. J., Holady, J. C., Rexing, D. J., & Snyder, S. A. (2006). Broad range analysis of endocrine disruptors and pharmaceuticals using gas chromatography and liquid chromatography tandem mass spectrometry. Chemosphere, 65, 1990-1998. (Pubitemid 44751860)
203. Trussell, R. R. (2001). Endocrine disruptors and the water industry. Journal of American Water Works Association, 93, 58-65. (Pubitemid 32869482)
204. 2 suspension reactor. Journal of Hazardous Materials, 168, 269-275.
205. Verma, A., Kaur, H., & Dixit, D. (2013). Photocatalytic, Sonolytic and Sonophotocatalytic Degradation of 4-Chloro-2-Nitro Phenol. Archives of Environmental Protection., 39(2), 17-28.
206. Vogel, J. M. (2004). Tunnel vision: The regulation of endocrine disruptors. Political Science, 37, 277-303. (Pubitemid 43055000)
207. 2 treatment of antiepileptic drug carbamazepine. Chemosphere, 54, 497-505. (Pubitemid 38044524)
208. 2 and Ozone. Water Research, 38, 414-422. (Pubitemid 38367704)
209. Vulliet, & Cren-Olivé, E. (2011). Screening of pharmaceuticals and hormones at the regional scale, in surface and groundwaters intended to human consumption. Environmental Pollution, 159, 2929-2934.
210. Writer, J. H., Barber, L. B., Brown, G. K., Taylor, H. E., Kiesling, R. L., Ferrey, M. L., Jahns, N. D., Bartell, S. E., & Schoenfuss, H. L. (2010). Anthropogenic tracers, endocrine disrupting chemicals, and endocrine disruption in Minnesota lakes. Science of the Total Environment, 409, 100-111.
211. Wu, C. X., Witter, J. D., Spongberg, A. L., & Czajkowski, K. P. (2009). Occurrence of selected pharmaceuticals in an agricultural landscape, western Lake Erie basin. Water Research, 43, 3407-3416.
212. Xia, K., Bhandari, A., Das, K., & Pillar, G. (2005). Occurrence and fate of pharmaceuticals and personal care products (PPCPs) in biosolids. Journal of Environmental Quality, 34, 91-104. (Pubitemid 40130044)
213. Xiao, R., Diaz-Rivera, D., & Linda, K. (2013). Weaver factors influencing pharmaceutical and personal care product degradation in aqueous solution using pulsed wave ultrasound. Industrial and Engineering Chemistry Research, 52, 2824-2831.
214. Xu, B., Gao, N. Y., Rui, M., Wang, H., & Wu, H. H. (2007). Degradation of endocrine disruptor bisphenol A in drinking water by ozone oxidation. Journal of Hazardous Materials, 138, 526-533.
215. Xu, J., Wu, L., Chen, W., & Chang, A. C. (2008). Simultaneous determination of pharmaceuticals, endocrine disrupting compounds and hormone in solids by gas chromatography-mass spectrometry. J. Chromatog., A, 1212, 189.
216. Xue, N., & Xu, X. (2006). Composition, distribution and characterization of suspected endocrine-disrupting pesticides in Beying GuanTing Reservoir (GTR). Archives of Environmental Contamination and Toxicology, 50, 463-473.
217. 2 photocatalysis. Water Research, 42, 3480-3488.
218. 2 nanoparticles on activated carbon fiber and its photodegradation performance for organic pollutants. Particuology, 8, 272-278.
219. Yin, H. S., Zhou, Y., & Ai, S. Y. (2009). Preparation and characteristic of cobalt phthalocyanine modified carbon paste electrode for bisphenol A detection. J. Electroanalytical Chem., 626(1-2), 80-88.
220. Yoon, Y., & Lueptow, R. M. (2005). Removal of organic contaminants by RO and NF membranes. J. Membrane Sci., 261, 76-86.
221. Yoon, Y., Westerhoff, P., Synder, S. A., & Wert, E. C. (2006a). Nanofiltration and ultrafiltration of endocrine disrupting compounds, pharmaceuticals and personal care products. J. Membrane Sci., 270, 88-100. (Pubitemid 43112388)
222. Yoon, Y., Westerhoff, P., Synder, S. A., Wert, E. C., & Yoon, J. (2006b). Removal of endocrine disrupting compounds by nanofiltration and ultrafiltration membranes. Desalination, 202, 16-23.
223. Yoon, Y., Westerhoff, P., Snyder, S. A., Wert, E. C., & Yoon, J. (2007). Removal of endocrine disrupting compounds and pharmaceuticals by nanofiltration and ultrafiltration membranes. Desalination, 202(1-3), 16-23. (Pubitemid 44829078)
224. Yu, C.-P., & Chu, K.-H. (2009). Occurrence of pharmaceuticals and personal care products along the West Prong Little Pigeon River in east Tennessee, USA. Chemosphere, 75, 1281-1286.
225. Yu, Z. R., Peldszus, S., & Huck, P. M. (2008). Adsorption characteristics of selected pharmaceuticals and an endocrine disrupting compound - naproxen, carbamazepine and nonylphenol - on activated carbon. Water Research, 42(12), 2873-2882.
226. 2 suspensions: Mechanism and kinetics. Catalysis Today, 129, 9-15. (Pubitemid 47628892)
227. Zala, S. M., & Penn, D. J. (2004). Abnormal behaviours induced by chemical pollution: A review of the evidence and new challenges. Animal Behaviour, 68, 649-664. (Pubitemid 39348045)
228. Zelmanov, G., & Semiat, R. (2008). Iron(3) oxide-based nanoparticles as catalysts in advanced organic aqueous oxidation. Water Research, 42, 492-498.
229. 2 in a rotating packed bed. Ozone: Science & Engineering, 35, 101-108.
230. Zhang, Y., & Zhou, J. L. (2008). Occurrence and removal of endocrine disrupting chemicals in wastewater treatment. Chemosphere, 73, 848-853.
231. 2-Coated photocatalytic reactor. Environmental Engineering Science, 29(3), 196-201.